Valentin Ortiz-Maldonado
Haematologist Hospital Clinic of Barcelona
Hematologist since 2017. PhD student on adoptive immunotherapy with T lymphocytes with Chimeric Antigen Receptors (CAR T-cells) for the treatment of malignant hemopathies. Involved in the development and implementation of the clincal CAR-T program for the treatment of patients with malignant blood diseases at the Hospital Clínic de Barcelona.
Seminars
Thursday 26th February 2026
Panel Discussion: Navigating Patient Selection & Eligibility in Europe to Ensure Timely Access to Cell Therapies
8:30 am
- Examine the complexities of trial design across oncology and autoimmune indications, including comorbidities, inpatient requirements, and overlapping recruitment efforts
- Discuss the readiness of Europe’s academic and healthcare ecosystems, from educating rheumatologists and haematologists to training medical staff in managing CAR-T related toxicities
- Highlight strategies to streamline patient identification and enrolment, including earlier eligibility assessments and addressing barriers such as hospital capacity and fragile patient timelines
Wednesday 25th February 2026
Evaluating Long-Term Outcomes of Approved CAR-T Therapies in Real- World Settings & Highlighting Upcoming CAR-T Therapies
10:00 am
- Share results from a multicentre Phase 2 trial in adult B-ALL, marking the first centralised EMA commercialisation request for a CAR-T product
- Compare real-world evidence of approved CAR-T and off-label B-cell lymphoma treatments to assess long-term efficacy and safety
- Discuss insights from Hospital Clinic Barcelona’s experience as one of Europe’s earliest CAR-T/TCR treatment centres
New Data
